]>
IRCT20180530039917N1 IRCT 2018-06-21 Vice Chancellor for Research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran Comparison of ketamine and dexmedetomidine in a reduction of shoulder dislocation Comparison the efficacy and side effects of ketamine and Dexmedetomidine in reduction of shoulder dislocation in patients referring to the emergency department of Ahwaz Imam Khomeini and Golestan Hospital in 2017 2017-06-23 anticipated 50 Complete https://irct.ir/trial/31927 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomize in two groups with quadri unit Permutational blocks, Blinding description: The patients know they are participating in a study that is aimed to compare the efficacy and side effects of ketamine and Dexmedetomidine in the reduction of shoulder dislocation but they are not informed that they receive placebo or Dexmedetomidine. The physician who evaluates the clinical status of patients and the nurse who injects the drug are not aware of the medication that patients receive. N/A Dislocation of shoulder. Intervention 1: The group will receive 1 Mg/Kg Ketamine nebulized. Intervention 2: The group will receive 1 micro gram/Kg Dexmedetomidine nebulized. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information
public Payam Ghoraian
Golestan
Ahvaz Iran (Islamic Republic of) 6455134358 +98 21 8670 5503 ghoraian.p@ajums.ac.ir Ahvaz University of Medical Sciences scientific Payam Ghoraian
Golestan
Ahvaz Iran (Islamic Republic of) 6455134358 +98 21 8670 5503 ghoraian.p@ajums.ac.ir Ahvaz University of Medical Sciences Iran (Islamic Republic of) Inferior and posterior dislocation of shoulder 14 - 65 aged 14 years 65 years Both Patients with fracture in the primary graph Excessive injury or open dislocation shoulder Patients with reduced consciousness Patients with deformity and neurological lesions in shoulder S43 Dislocation and sprain of joints and ligaments of shoulder girdle Treatment - Drugs Treatment - Drugs The group will receive 1 Mg/Kg Ketamine nebulized The group will receive 1 micro gram/Kg Dexmedetomidine nebulized What is the mean value of VAS score in patients undergoing comorbid reduction of ketamine and doxedetomidine before the intervention at 5, 10, 20, 30 and 60 minutes after receiving the drug?. Timepoint: 0,5,10,20 30, 60 minutes after treatmen. Method of measurement: VAS questionnaire. Vice Chancellor for Research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran Approved 2638-09-02 Ethical commite of Jundishapur University of Ahvaz Golestan Ahvaz Khouzestan Iran (Islamic Republic of)